A Longitudinal Observational Follow-up of the PRECEPT Study Cohort
A Longitudinal Observational Follow-up of the PRECEPT Study Cohort
The purpose of this study is to longitudinally follow consenting clinical trial participants
 who participated in PRECEPT (A Randomized, Double Blind, Placebo Controlled, Dose Finding
 Study to Assess the Efficacy and Safety of CEP 1347 in Patients With Early Parkinson's
 Disease). The study will assess the clinical and imaging outcomes relevant to the natural
 history of Parkinson's disease (PD), as well as determine early biomarkers of the disease.
Inclusion Criteria:

 -  Participation in the PRECEPT study

 -  Willing and able to give informed consent

 Exclusion Criteria:

 -  Patients will be excluded from participating in the the study if either of the
 criteria stated above is not met